ABSTRACT Background Antimicrobial resistance (AMR) is one of the most urgent global public health threats, especially in low‐ and middle‐income countries. In 2019, bacterial AMR wa
ABSTRACT Background and Aims As the use of metabolic and bariatric surgery (MBS) expands, clinicians increasingly encounter weight recurrence, suboptimal response, gastroesophageal
ABSTRACT Background and Aims CRISPR‐Cas9 gene editing has transformed molecular biology and has great potential as a therapeutic tool for cancer and many other human diseases. This
ABSTRACT Background and Aims Diabetes mellitus contributes significantly to the global disease burden, affecting approximately 537 million adults worldwide, with over 75% residing
A well-designed retrospective cohort study with clear epidemiological evidence (RR 9.7, 95% CI 4.1–22.6) linking a specific food preparation practice to acute gastroenteritis, but limited by single-site setting, negative pathogen culture, and lack of microbiological confirmation of causation.
This is a narrative review synthesizing literature on CVD epidemiology, pathophysiology, and emerging therapies including phytotherapy, without original data or comparative evidence to support specific clinical claims.
A population-level epidemiological analysis using established GBD methodology that documents and confirms the rising burden of type 2 diabetes in MENA countries; descriptive rather than interventional, with no novel mechanistic or clinical insights.
Computational immunology design study with no experimental validation, animal testing, or clinical data; raises questions about vaccine candidate feasibility but does not answer them.